市场调查报告书
商品编码
1467669
2024-2032 年按服务类型(病史和身体报告、出院摘要、手术记录或报告、咨询报告等)、技术、采购模式、最终用户和地区分類的近距离放射治疗市场报告Brachytherapy Market Report by Service Type (History and Physical Report, Discharge Summary, Operative Note or Report, Consultation Report, and Others ), Technology, Mode of Procurement, End-User, and Region 2024-2032 |
IMARC Group年,全球近距离放射治疗市场规模达8.564亿美元。
近距离放射治疗,也称为内部放射治疗,是放射治疗的一种形式,其中放射线直接通过植入体内癌性肿瘤附近或旁边的源传输。此源产生的伽马射线聚焦于癌细胞并减少对周围健康组织的损害。根据疾病及其损害的严重程度,近距离放射治疗可以低剂量率 (LDR) 或高剂量率 (HDR) 进行。对于 LDR,小型放射性种子会永久植入肿瘤内或肿瘤周围,而对于 HDR,放射源在每次疗程结束时从患者体内移除,并用于高风险癌症的情况。
不同类型癌症盛行率的上升是推动全球市场的关键因素之一。近距离放射治疗已被证明是治疗子宫颈癌、皮肤癌和乳癌的一种极其有效的治疗选择,这对其市场成长做出了重大贡献。此外,高品质的近距离放射治疗设备可以为小肿瘤提供精确且极为局部的放射剂量,这提高了患者和医疗专业人员对治疗的接受度。肿瘤治疗的技术进步和广泛的研究和开发(R&D),例如治疗新生血管性老年黄斑部病变的试验,也极大地推动了市场成长。除此之外,全球医疗旅游的不断增长,以及人们对近距离放射治疗的优势及其成本效益的认识不断提高,以及与手术或外照射治疗(EBT) 相比治癒率的提高,也显着推动了市场的发展。
IMARC 集团的最新报告深入洞察了全球近距离放射治疗市场,涵盖了其所有重要方面。内容涵盖从宏观市场概况到微观细节的行业表现、近期趋势、关键市场驱动因素和挑战、SWOT分析、波特五力分析、价值链分析等。 、研究人员、顾问、商业策略家以及所有拥有任何利益或计划以任何方式进军全球近距离治疗市场的人。
The global brachytherapy market size reached US$ 856.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,195.9 Million by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032.
Brachytherapy, also known as internal radiation therapy, is a form of radiotherapy in which radiation is transported directly through a source implanted near or next to the cancerous tumor in the body. The source produces gamma rays that are focused on cancer cells and reduce the damage to surrounding healthy tissue. Brachytherapy is either administered in Low Dose Rate (LDR) or High Dose Rate (HDR) depending upon the severity of the disease and its damage. For LDR, small radioactive seeds are implanted permanently in or around the tumor, whereas, for HDR, radioactive sources are removed from the patient's body at the termination of each session and is used in the cases of high-risk cancers.
The rising prevalence of different types of cancer is one of the key factors driving the global market. Brachytherapy has been proven to be an extremely effective treatment option for cervical, skin and breast cancers, which is contributing significantly to its market growth. Furthermore, the availability of high-quality brachytherapy equipment that provides accurate and extremely localized doses of radiation to small tumors has enhanced the acceptance of the therapy amongst patients and medical professionals alike. Technological advancements in oncology treatments and extensive research and development (R&D), such as trials for treating neovascular age-related macular degeneration, have also provided a significant boost to the market growth. In addition to this, growing medical tourism across the globe, along with increasing awareness about the advantages of brachytherapy and its cost-effectiveness and increasing cure rate as compared to surgery or external beam therapy (EBT), is also significantly driving the market.
IMARC Group's latest report provides a deep insight into the global brachytherapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the global brachytherapy market in any manner.
IMARC Group provides an analysis of the key trends in each sub-segment of the global brachytherapy market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on service type, technology, mode of procurement and end-user.
History and Physical Report
Discharge Summary
Operative Note or Report
Consultation Report
Others (Pathology Report, Radiology Report, etc.)
EMR/EHR
PACS
RIS
SRT
Others
Outsourcing
Offshoring
Both
Hospitals
Clinics
Clinical Laboratories
Academic Medical Centers
Others
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
The report has also analyzed the competitive landscape of the market with some of the key players being Acusis Software India Pvt Ltd., Transcend Services, Inc., Naunce Communications, Inc., MModal Global Services Pvt. Ltd., iMedX Information Services Pvt. Ltd., Global Medical Transcription LLC, nThrive Solutions LLC, MTBC (CareCloud, Inc.), Medi-Script Plus and Transtech Medical Solutions LLC.